A Study to Learn About the Study Medicine Called PF-08165784 in People With PIK3CA-Mutated Advanced or Metastatic Solid Tumors
Conditions
- Advanced Breast Cancer
- Advanced or Metastatic Breast Cancer
- Metastatic Breast Cancer (HR+/ HER2-)
- Metastatic Colorectal Adenocarcinoma
Interventions
- DRUG: PF-08165784
- DRUG: Fulvestrant
- DRUG: Atirmociclib
- DRUG: Cetuximab
- DRUG: Letrozole
Sponsor
Pfizer